United States: CMS Proposes Major ACO Overhaul

Miranda Franco is a Senior Policy Advisor in Holland & Knight's Washington D.C. office

On Aug. 9, 2018, Centers for Medicare and Medicaid Services (CMS) released a proposed rule that would update the Medicare Shared Savings Program (MSSP). Called "Pathways to Success," the proposal significantly alters the Accountable Care Organization (ACO) program. CMS estimates that these changes will save the federal government $2.24 billion over the next ten years, primarily due to a $2.17 billion reduction in ACO net earnings.

Uncertainty for ACOs

There are currently 561 ACOs participating in the Shared Savings program that have approximately 10.5 million assigned beneficiaries—with the vast majority only participating in one-sided risk arrangements. CMS' proposed changes to the MSSP create uncertainty for future ACO participation. Given the limited years of one-sided risk available, a lower amount of potential shared savings, and long transition to Advanced Alternative Payment Model (APM) status, it is unclear how current ACOs and providers considering forming an ACO will participate in the program. CMS estimates that 20 ACOs will drop out of the program in 2019 and 109 ACOs will drop out of the program by 2028.

CMS Consolidates Tracks to Basic and Enhanced

Notably, CMS proposes to retire the current Track 1 and Track 2 options and replace them with a new model, the "BASIC" track. CMS also proposes to modify agreement periods from 3-years to 5-years. The BASIC track would feature a glide path for taking risk. Currently, ACOs have up to six years to shift to a model where they share in the financial risk. As proposed, BASIC ACOs will be forced to assume risk within two years while gradually transitioning to higher risk in years three, four, and five, concluding in year five at a level of risk that meets the standard to qualify as an Advanced APM under the Medicare Access and CHIP Reauthorization Act (MACRA). Current upside-only ACOs would be limited to one year without risk before being required to transition to the risk level in year three of the glide path. The percentage of maximum savings will be cut in half from current levels. CMS also proposes to retain Track 3 but rebrand it as the "ENHANCED" track.

Updated Timeline and Beneficiary Assignment Changes

To ease the transition, CMS says it will start new ACO agreements in July 2019 rather than January of next year. ACOs currently in the program would have an option to extend their participation agreement through the end of next June. The usual application cycle will pick up again in January 2020. All ACOs may annually choose a beneficiary assignment methodology (preliminary prospective assignment with retrospective reconciliation, or prospective assignment) as well as whether to opt into two-sided risk under the BASIC track.

ACOs that are low-revenue—which CMS says are mostly physician and rural ACOs—could participate in the basic track for two five-year periods, under the proposal. However, the high-revenue ACOs, which are mostly those that include hospitals, would be required under the proposed rule to move to the enhanced track after one five-year agreement period.

Changes to Benchmark Calculations

CMS is also proposing multiple updates to the calculation of the benchmark amounts. The following updates are included in the proposal:

  • Move benchmarks towards reflecting the costs of care delivered in the ACO's region, instead of the ACO's historical performance;
  • Mitigate the effects of excessive positive or negative regional adjustment used to establish and reset benchmarks;
  • Blend national and regional expenditure growth rates, with increasing weight placed on the national component of the blend as the ACO's penetration in its region increases; and
  • Use the full CMS-Hierarchical Condition Category (HCC) risk score to adjust benchmark performance to better account for certain health status changes.

CEHRT Requirements

The proposal also seeks to discontinue the ACO electronic health record (EHR) quality measure (ACO-11) and instead establish an interoperability criterion based solely on the level of use of certified electronic health record technology (CEHRT) to determine eligibility for program participation. Specifically, ACOs that would not be considered advanced APMs under the MACRA would need to attest that at least 50 percent of eligible clinicians use CEHRT, while ACOs that would be considered AAPMs would need to attest to the level of CEHRT requirements outlined in the Quality Payment Program (QPP).

Skilled Nursing Facility (SNF) Waiver

CMS is also proposing to expand waiver availability that allows beneficiaries to transfer to a skilled nursing facility (SNF) with an inpatient stay of fewer than three days. Currently, CMS allows only Track 3 and Track 1+ ACOs with prospective beneficiary assignment to use the SNF waiver. However, CMS is proposing to allow use of the SNF 3-day waiver by ACOs in two-sided risk contracts in the Basic and Enhanced Tracks, regardless of prospective beneficiary assignment (Track 3) or preliminary prospective assignment with retrospective reconciliation (Track 1 and Track 2). Also, CMS proposes to amend the existing waiver design to allow critical access hospitals and other small, rural hospitals operating under a swing bed agreement to be eligible to partner with eligible ACOs as SNF affiliates under the three-day waiver.

BBA Implementation

The rule also implements some provisions of the Bipartisan Budget Agreement (BBA) of 2018, including expanding the use of telehealth for two-sided ACOs, allowing for prospective beneficiary assignment to an ACO, allowing for beneficiary incentives, and letting beneficiaries designate their primary clinician.

Comment Period

CMS is looking to update the program's quality measure set as part of the agency's Meaningful Measures initiative for addressing opioid epidemic and addition by adding three new measures. The agency seeks comments on the addition of any other measures related to aspects of opioid use or opioid use disorder treatment and suggestions on any information and aggregate data that would be useful to ACOs to combat opioid misuse in their beneficiary population.

The proposed rule is expected to appear in the Federal Register on Aug. 17, 2018, and comments are due on Oct. 16, 2018.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions